Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines

British Journal of Haematology

Volumn 173, Issue 6, 2016, Pages 927-937

  Couque, Nathalie ^a   Girard, Delphine ^a,b   Ducrocq, Rolande ^a   Boizeau, Priscilla ^a   Haouari, Zinedine ^a,c   Missud, Florence ^a,c   Holvoet, Laurent ^a,c   Ithier, Ghislaine ^a,c   Belloy, Marie ^d   Odièvre, Marie Héléne ^e   Benemou, Michel ^f   Benhaim, Patricia ^g   Retali, Brigitte ^h   Bensaid, Philippe ⁱ   Monier, Brigitte ^j   Brousse, Valentine ^k   Amira, Roger ^l   Orzechowski, Christine ^m   Lesprit, Emmanuelle ⁿ   Mangyanda, Laurent ^o   Garrec, Nathalie ^p   Elion, Jacques ^a,b,q   Alberti, Corinne ^a,b,r   Baruchel, André ^a,b,s   Benkerrou, Malika ^a,c,r   more..

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Centre de Référence de la Drépanocytose   (France)

^d Centre Hospitalier Robert Ballanger CHRB   (France)

^e HÔPITAL LOUIS MOURIER   (France)

^f Hôpital de Gonesse   (France)

^g HÔPITAL JEAN VERDIER   (France)

^h CENTRE HOSPITALIER RENÉ DUBOS   (France)

ⁱ CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^j Emile Roux Hospital AP HP   (France)

^k HÔPITAL NECKER ENFANTS MALADES   (France)

^l Centre Hospitalier de Saint Denis   (France)

^m Centre Hospitalier de Bry Sur Marne   (France)

ⁿ ARMAND TROUSSEAU HOSPITAL   (France)

^o CHI des Portes de l'Oise   (France)

^p Centre Hospitalier Marne la Vallée Hospital   (France)

^q hôpital Robert Debré et Institut national de la transfusion sanguine   (France)

^r Paris Diderot University   (France)

^s UNIVERSITÉ PARIS DIDEROT   (France)

more..

Author keywords

hydroxycarbamide; mortality; newborn screening; sickle cell disease; transfusion

Indexed keywords

FOLIC ACID; HEMOGLOBIN; HEPATITIS B VACCINE; HYDROXYUREA; OPIATE DERIVATIVE; PENICILLIN V; PNEUMOCOCCUS VACCINE;

ACUTE CHEST SYNDROME; ACUTE DISEASE; ACUTE SPLENIC SEQUESTRATION; ANEMIA; ARTICLE; BETA THALASSEMIA; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; FRANCE; GENOTYPE; HEALTH CARE QUALITY; HEPATITIS B; HIGH RISK PATIENT; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MULTICENTER STUDY (TOPIC); NEWBORN; NEWBORN CARE; ONLINE SYSTEM; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; SPLEEN DISEASE; SURVIVAL TIME; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; VEIN OCCLUSION;

EID: 84973643658     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14015     Document Type: Article

References (42)

1. Adamkiewicz, T.V., Silk, B.J., Howgate, J., Baughman, W., Strayhorn, G., Sullivan, K. & Farley, M.M. (2008) Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics, 121, 562–569.
2. Adams, R.J., Nichols, F.T., Figueroa, R., McKie, V. & Lott, T. (1992) Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke, 23, 1073–1077.
3. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New England Journal of Medicine, 339, 5–11.
4. AFDPHE (2013) Bilan d'activité de l'Association Française de Dépistage et de Prévention des Handicaps de l'Enfant http://www.afdphe.org/sites/default/files/bilan_activite_2013.pdf.
5. Almeida, A.M., Henthorn, J.S. & Davies, S.C. (2001) Neonatal screening for haemoglobinopathies: the results of a 10-year programme in an English Health Region. British Journal of Haematology, 112, 32–35.
6. ARS (2011) [Health status in the Ile-de-France: diagnostic elements.]. Available at: http://www.ars.iledefrance.sante.fr/fileadmin/ILE-DE-FRANCE/ARS/1_Votre_ARS/3_Nos_Actions/3_PRS/Note_diagnostic_pour_PSRS_180111_pdf.pdf. pp. 1-12.
7. Bardakdjian-Michau, J., Bahuau, M., Hurtrel, D., Godart, C., Riou, J., Mathis, M., Goossens, M., Badens, C., Ducrocq, R., Elion, J. & Perini, J.M. (2009) Neonatal screening for sickle cell disease in France. Journal of Clinical Pathology, 62, 31–33.
8. Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coic, L., Leveille, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galacteros, F., Torres, M., Kuentz, M., Ferry, C., Socie, G., Reinert, P. & Delacourt, C. (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood, 117, 1130–1140; quiz 1436.
9. Brandow, A.M., Jirovec, D.L. & Panepinto, J.A. (2010) Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization. American Journal of Hematology, 85, 611–613.
10. Ducrocq, R., Pascaud, O., Bevier, A., Finet, C., Benkerrou, M. & Elion, J. (2001) Strategy linking several analytical methods of neonatal screening for sickle cell disease. Journal of Medical Screening, 8, 8–14.
11. Galacteros, F., Kleman, K., Caburi-Martin, J., Beuzard, Y., Rosa, J. & Lubin, B. (1980) Cord blood screening for hemoglobin abnormalities by thin layer isoelectric focusing. Blood, 56, 1068–1071.
12. Gaston, M.H., Verter, J.I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., Zarkowsky, H., Vichinsky, E., Iyer, R., Lobel, J.S., Diamond, S., Holbrook, C.T., Gill, F.M., Ritchey, K. & Falletta, J.M. and For the Prophylactic Penicillin Study Group (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med, 314, 1593–1599.
13. Gill, F.M., Sleeper, L.A., Weiner, S.J., Brown, A.K., Bellevue, R., Grover, R., Pegelow, C.H. & Vichinsky, E. (1995) Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood, 86, 776–783.
14. Hamideh, D. & Alvarez, O. (2013) Sickle cell disease related mortality in the United States (1999-2009). Pediatric Blood & Cancer, 60, 1482–1486.
15. Hankins, J.S., Aygun, B., Nottage, K., Thornburg, C., Smeltzer, M.P., Ware, R.E. & Wang, W.C. (2014) From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia. Medicine, 93, e215.
16. HAS (2010) Syndromes drépanocytaires majeurs de l'enfant et de l'adolescent. Haute Autorité de Santé, Saint-Denis La Plaine, France. Available at: http://www.has-sante.fr/portail/jcms/c_9o38888/ald-n-10-pnds-sur-syndromes-drepanocytaires-majeurs-de-l-enfant-et-de-l-adolescent
17. Kmietowicz, Z. (2004) Screening for sickle cell disease and thalassaemia saving lives. BMJ, 329, 69.
18. Le, P.Q., Gulbis, B., Dedeken, L., Dupont, S., Vanderfaeillie, A., Heijmans, C., Huybrechts, S., Devalck, C., Efira, A., Dresse, M.F., Rozen, L., Benghiat, F.S. & Ferster, A. (2015) Survival among children and adults with sickle cell disease in Belgium: benefit from hydroxyurea treatment. Pediatric Blood and Cancer, 62, 1956–1961.
19. Lee, A., Thomas, P., Cupidore, L., Serjeant, B. & Serjeant, G. (1995) Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ, 311, 1600–1602.
20. Lobo, C.L., Pinto, J.F., Nascimento, E.M., Moura, P.G., Cardoso, G.P. & Hankins, J.S. (2013) The effect of hydroxcarbamide therapy on survival of children with sickle cell disease. British Journal of Haematology, 161, 852–860.
21. McCavit, T.L., Quinn, C.T., Techasaensiri, C. & Rogers, Z.R. (2011) Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure. Journal of Pediatrics, 158, 505–507.
22. McKie, K.T., Hanevold, C.D., Hernandez, C., Waller, J.L., Ortiz, L. & McKie, K.M. (2007) Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 29, 140–144.
23. Miller, S.T., Sleeper, L.A., Pegelow, C.H., Enos, L.E., Wang, W.C., Weiner, S.J., Wethers, D.L., Smith, J. & Kinney, T.R. (2000) Prediction of adverse outcomes in children with sickle cell disease. New England Journal of Medicine, 342, 83–89.
24. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288–294.
25. Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. (1991) Pain in sickle cell disease. Rates and risk factors. New England Journal of Medicine, 325, 11–16.
26. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639–1644.
27. Powars, D., Chan, L.S. & Schroeder, W.A. (1990) The variable expression of sickle cell disease is genetically determined. Seminars in Hematology, 27, 360–376.
28. Quinn, C.T., Rogers, Z.R. & Buchanan, G.R. (2004) Survival of children with sickle cell disease. Blood, 103, 4023–4027.
29. Quinn, C.T., Rogers, Z.R., McCavit, T.L. & Buchanan, G.R. (2010) Improved survival of children and adolescents with sickle cell disease. Blood, 115, 3447–3452.
30. Runel-Belliard, C., Lesprit, E., Quinet, B. & Grimprel, E. (2009) Sickle cell children traveling abroad: primary risk is infection. Journal of Travel Medicine, 16, 253–257.
31. Sommet, J., Missud, F., Holvoet, L., Ithier, G., Lorrot, M., Benkerrou, M. & Faye, A. (2013) Morbidity among child travellers with sickle-cell disease visiting tropical areas: an observational study in a French tertiary care centre. Archives of Disease in Childhood, 98, 533–536.
32. Steinberg, M.H., McCarthy, W.F., Castro, O., Ballas, S.K., Armstrong, F.D., Smith, W., Ataga, K., Swerdlow, P., Kutlar, A., DeCastro, L. & Waclawiw, M.A. (2010) The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. American Journal of Hematology, 85, 403–408.
33. Stettler, N., McKiernan, C.M., Melin, C.Q., Adejoro, O.O. & Walczak, N.B. (2015) Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea. JAMA, 313, 1671–1672.
34. Strouse, J.J. & Heeney, M.M. (2012) Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children. Pediatric Blood & Cancer, 59, 365–371.
35. Telfer, P., Coen, P., Chakravorty, S., Wilkey, O., Evans, J., Newell, H., Smalling, B., Amos, R., Stephens, A., Rogers, D. & Kirkham, F. (2007) Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica, 92, 905–912.
36. Thornburg, C.D., Files, B.A., Luo, Z., Miller, S.T., Kalpatthi, R., Iyer, R., Seaman, P., Lebensburger, J., Alvarez, O., Thompson, B., Ware, R.E. & Wang, W.C. (2012) Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood, 120, 4304–4310; quiz 4448.
37. Vichinsky, E., Hurst, D., Earles, A., Kleman, K. & Lubin, B. (1988) Newborn screening for sickle cell disease: effect on mortality. Pediatrics, 81, 749–755.
38. Vichinsky, E.P., Styles, L.A., Colangelo, L.H., Wright, E.C., Castro, O. & Nickerson, B. (1997) Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood, 89, 1787–1792.
39. Voskaridou, E., Christoulas, D., Bilalis, A., Plata, E., Varvagiannis, K., Stamatopoulos, G., Sinopoulou, K., Balassopoulou, A., Loukopoulos, D. & Terpos, E. (2010) The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood, 115, 2354–2363.
40. Wang, W.C., Ware, R.E., Miller, S.T., Iyer, R.V., Casella, J.F., Minniti, C.P., Rana, S., Thornburg, C.D., Rogers, Z.R., Kalpatthi, R.V., Barredo, J.C., Brown, R.C., Sarnaik, S.A., Howard, T.H., Wynn, L.W., Kutlar, A., Armstrong, F.D., Files, B.A., Goldsmith, J.C., Waclawiw, M.A., Huang, X. & Thompson, B.W. (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet, 377, 1663–1672.
41. Wheatley, K. (2002) SAB–a promising new treatment to improve remission rates in AML in the elderly? British Journal of Haematology, 118, 432–433.
42. Yawn, B.P., Buchanan, G.R., Afenyi-Annan, A.N., Ballas, S.K., Hassell, K.L., James, A.H., Jordan, L., Lanzkron, S.M., Lottenberg, R., Savage, W.J., Tanabe, P.J., Ware, R.E., Murad, M.H., Goldsmith, J.C., Ortiz, E., Fulwood, R., Horton, A. & John-Sowah, J. (2014) Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA, 312, 1033–1048.